03rd week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200016203 | Cell | 2020-01-16 |
20200016204 | CELL | 2020-01-16 |
20200016205 | Suppression of Microglial Activation with Innate Lymphoid Cells | 2020-01-16 |
20200016206 | IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD USING AN INTERLEUKIN-2 RECEPTOR ALPHA, BETA-SELECTIVE AGONIST IN COMBINATION WITH ADOPTIVE CELL TRANSFER THERAPY | 2020-01-16 |
20200016207 | TRANSGENIC c-MPL PROVIDES LIGAND-DEPENDENT CO-STIMULATION AND CYTOKINE SIGNALS TO TCR-ENGINEERED T CELLS | 2020-01-16 |
20200016208 | Stimulatory Cell Lines For Ex Vivo Expansion And Activation Of Natural Killer Cells | 2020-01-16 |
20200016209 | METHODS RELATED TO ENGINEERED ERYTHOID CELLS COMPRISING 4-1BBL | 2020-01-16 |
20200016210 | Methods of Reducing Teratoma Formation During Allogeneic Stem Cell Therapy | 2020-01-16 |
20200016211 | MESENCHYMAL STEM CELLS AND PHARMACEUTICAL COMPOSITION | 2020-01-16 |
20200016212 | DOMINANT ACTIVE YAP, A HIPPO EFFECTOR, INDUCES CHROMATIN ACCESSIBILITY AND CARDIOMYOCYTE RENEWAL | 2020-01-16 |
20200016213 | Methods of Treating Cerebral Palsy Using High Dose Allogeneic Umbilical Cord Blood | 2020-01-16 |
20200016214 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | 2020-01-16 |
20200016215 | BIOACTIVE MUSSEL COMPOSITIONS AND/OR EXTRACTS | 2020-01-16 |
20200016216 | AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM | 2020-01-16 |
20200016217 | DIRECT-FED MICROBIALS | 2020-01-16 |
20200016218 | METHODS AND COMPOSITIONS FOR TREATING ULCERATIVE COLITIS | 2020-01-16 |
20200016219 | Foods Containing Beneficial Oral Bacteria | 2020-01-16 |
20200016220 | BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS INFECTION | 2020-01-16 |
20200016221 | METHOD FOR PRODUCING CULTURE PRODUCT OF LACTOBACILLUS PLANTARUM | 2020-01-16 |
20200016222 | PHARMACEUTICAL COMPOSITION COMPRISING CODIUM FRAGILE EXTRACT AS EFFECTIVE INGREDIENT FOR PROTECTING OR TREATING ARTICULAR CARTILAGE | 2020-01-16 |
20200016223 | GINSENG-DERIVED NANOPARTICLE AND PREPARATION AND APPLICATION THEREOF | 2020-01-16 |
20200016224 | ENHANCER FOR CATECHIN UPTAKE IN ENTEROCYTES | 2020-01-16 |
20200016225 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES WHICH INCLUDES FLOWER EXTRACT OF DAPHNE GENKWA OR FRACTIONS THEREOF AS ACTIVE INGREDIENT | 2020-01-16 |
20200016226 | PLANT BASED EMOLLIENT | 2020-01-16 |
20200016227 | ANTIMICROBIAL GARLIC COMPOSITIONS | 2020-01-16 |
20200016228 | ORALLY ADMINISTERED COMPOSITION FOR TREATING CYSTIC FIBROSIS, COPD, ASTHMA AND OTHER INFLAMMATORY CONDITIONS | 2020-01-16 |
20200016229 | AGENT FOR INHIBITING OR REDUCING LIGHT SENSITIVITY | 2020-01-16 |
20200016230 | PEPTIDE FOR TREATING OCULAR DISEASES AND COMPOSITION FOR TREATING OCULAR DISEASES COMPRISING SAME | 2020-01-16 |
20200016231 | BIOFILM DISRUPTING COMPOSITION | 2020-01-16 |
20200016232 | COMPOSITIONS AND METHODS FOR REGULATING BLOOD PRESSURE | 2020-01-16 |
20200016233 | Molecular Composition for Enhancing and Rejuvenating Maintenance and Repair of Mammalian Tissues | 2020-01-16 |
20200016234 | FGF RECEPTOR LIGANDS FOR TREATING DIABETES AND OBESITY | 2020-01-16 |
20200016235 | HIGHLY CONCENTRATED FORMULATIONS AND METHODS FOR PRODUCING LARGE BATCH PHARMACEUTICAL FORMULATIONS | 2020-01-16 |
20200016236 | TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2020-01-16 |
20200016237 | Methods, Compounds and Compositions for Modulating Blood Brain Barrier Integrity and Re-myelination | 2020-01-16 |
20200016238 | CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES | 2020-01-16 |
20200016239 | IL-15-BASED MOLECULES AND METHODS OF USE THEREOF | 2020-01-16 |
20200016240 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | 2020-01-16 |
20200016241 | TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY | 2020-01-16 |
20200016242 | HEMOGLOBIN BASED OXYGEN CARRIER AND METHOD OF PREPARATION | 2020-01-16 |
20200016243 | TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68 | 2020-01-16 |
20200016244 | TREATMENT FOR BK POLYOMAVIRUS INFECTION | 2020-01-16 |
20200016245 | GLYCOSIDE HYDROLASES TO TREAT BIOFILM-ASSOCIATED INFECTIONS | 2020-01-16 |
20200016246 | PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS | 2020-01-16 |
20200016247 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CNS INJURIES | 2020-01-16 |
20200016248 | TREATMENT OF PRURITUS IN HORSES | 2020-01-16 |
20200016249 | IL-23-P19 VACCINES | 2020-01-16 |
20200016250 | METHODS AND COMPOSITIONS USING RECOMBINANT DENDRITIC CELLS FOR CANCER THERAPY | 2020-01-16 |
20200016251 | Compositions and Methods of Identifying Tumor Specific Neoantigens | 2020-01-16 |
20200016252 | CYCLOPHOSPHAMIDE ANALOGS FOR USE AS IMMUNOGENS AND ASSAY CONJUGATES FOR AN IMMUNOASSAY OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE | 2020-01-16 |
20200016253 | METHOD FOR DESIGNING RIG-I LIGANDS | 2020-01-16 |
20200016254 | Neoepitope vaccine and minnune stimulant combinations and methods | 2020-01-16 |
20200016255 | WT1 HELPER PEPTIDES AND COMBINATIONS OF WT1 HELPER PEPTIDE AND CONJUGATE OF CANCER ANTIGEN PEPTIDES | 2020-01-16 |
20200016256 | IMMUNE RESPONSE MODULATION USING LIVE BIOTHERAPEUTICS, FOR CONDITIONS SUCH AS ALLERGY DESENSITIZATION | 2020-01-16 |
20200016257 | SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 2 | 2020-01-16 |
20200016258 | NOVEL TARGETS OF ACINETOBACTER BAUMANNII | 2020-01-16 |
20200016259 | EPIZOOTIC HEMORRHAGIC DISEASE VACCINE | 2020-01-16 |
20200016260 | USE OF A GENETICALLY MODIFIED INFECTIOUS MEASLES VIRUS WITH ENHANCED PRO-APOPTOTIC PROPERTIES (MV-DELTAC VIRUS) IN CANCER THERAPY | 2020-01-16 |
20200016261 | Methods of Treating CMV Retinitis by T Cell Therapy | 2020-01-16 |
20200016262 | Targeting Moiety Peptide Epitope Complexes Having a Plurality of T-Cell Epitopes | 2020-01-16 |
20200016263 | VACCINES AGAINST HEPATITIS B VIRUS | 2020-01-16 |
20200016264 | NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT | 2020-01-16 |
20200016265 | iNOS-INHIBITORY COMPOSITIONS FOR TREATING CANCER | 2020-01-16 |
20200016266 | Methods for Modulating Angiogenesis of Cancers Refractory to Anti-VEGF Treatment | 2020-01-16 |
20200016267 | AQUEOUS ANTI-PD-L1 ANTIBODY FORMULATION | 2020-01-16 |
20200016268 | LIQUID PHARMACEUTICAL COMPOSITION | 2020-01-16 |
20200016269 | NEAR INFRARED ABSORBING DYE-BASED COMPOSITE PARTICLES EXHIBITING PHOTOTHERMAL EFFECT, METHOD FOR MANUFACTURING THE SAME, AND USE THEREOF | 2020-01-16 |
20200016270 | SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND | 2020-01-16 |
20200016271 | TOPICAL TETRACYCLINE COMPOSITIONS | 2020-01-16 |
20200016272 | COMPOSITIONS COMPRISING METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | 2020-01-16 |
20200016273 | COMPOSITIONS COMPRISING METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | 2020-01-16 |
20200016274 | MESSENGER RNA VACCINES AND USES THEREOF | 2020-01-16 |
20200016275 | Human Antibodies to S. Aureus Hemolysin A Toxin | 2020-01-16 |
20200016276 | ANTIBODY-DRUG CONJUGATES BASED ON GOLD COMPOUNDS | 2020-01-16 |
20200016277 | NANOPARTICLES FOR ACTIVE AGENT DELIVERY TO BRAIN CANCERS | 2020-01-16 |
20200016278 | STABLE GENE TRANSFER TO PROLIFERATING CELLS | 2020-01-16 |
20200016279 | MeCP2 EXPRESSION CASSETTES | 2020-01-16 |
20200016280 | Compositions For Enhancing Transport Of Molecules Into Cells | 2020-01-16 |
20200016281 | TREATMENT OF PMSA EXPRESSING CANCERS | 2020-01-16 |
20200016282 | Methods For Diagnosing And Monitoring Eosinophilic Esophagitis | 2020-01-16 |
20200016283 | COMBINATION THERAPY COMPRISING A RADIOPHARMACEUTICAL AND A DNA-REPAIR INHIBITOR | 2020-01-16 |
20200016284 | SHIELDING ASSEMBLY FOR A RADIOISOTOPE DELIVERY SYSTEM HAVING MULTIPLE RADIATION DETECTORS | 2020-01-16 |
20200016285 | Safe Serve Utensil Sanitizing Cover | 2020-01-16 |
20200016286 | Production of Immune-Response-Stimulating Aerosols By Non-Thermal Plasma Treatment Of Airborne Pathogens | 2020-01-16 |
20200016287 | SILVER NANOPARTICLE-ENHANCED PHOTOSENSITIZERS AS ANTIBIOFILM AGENTS | 2020-01-16 |
20200016288 | Electric Light Radiant Energy Control Systems | 2020-01-16 |
20200016289 | MOBILE STERILIZATION APPARATUS AND METHOD FOR USING THE SAME | 2020-01-16 |
20200016290 | COMPOSITIONS AND METHODS INVOLVING PROBIOTIC MOLECULES | 2020-01-16 |
20200016291 | Antimicrobial Adhesives Having Improved Properties | 2020-01-16 |
20200016292 | DEVICE FOR DELIVERY OF POWDERED HEMOSTATIC AGENTS | 2020-01-16 |
20200016293 | BONE SUBSTITUTE MATERIAL | 2020-01-16 |
20200016294 | Method for Preparing Porous Scaffold for Tissue Engineering, Cell Culture and Cell Delivery | 2020-01-16 |
20200016295 | INJECTABLE SCAFFOLDS FOR SOFT TISSUE REPAIR | 2020-01-16 |
20200016296 | MENINGEAL REPAIR USING HUMAN UMBILICAL CORD PATCHES | 2020-01-16 |
20200016297 | MATRIX SCAFFOLD WITH ANTIMICROBIAL ACTIVITY | 2020-01-16 |
20200016298 | COATED MEDICAL DEVICE AND METHOD OF COATING SUCH A DEVICE | 2020-01-16 |
20200016299 | COATED MEDICAL DEVICE AND METHOD OF COATING SUCH A DEVICE | 2020-01-16 |
20200016300 | HYDROGEL | 2020-01-16 |
20200016301 | DEVICE FOR USE IN ENDOLUMINAL VACUUM THERAPY | 2020-01-16 |
20200016302 | THERAPY APPARATUS WITH INTEGRATED FLUID CONDUCTORS AND NOISE ATTENUATION | 2020-01-16 |